O-1269

O-1269 is a synthetic compound of the cannabinoid family. It is a selective agonist for the CB1 receptor, and was developed for medical use by Organix Inc.

Chemistry[edit | edit source]

O-1269 is a member of the cannabinoid family of compounds, which also includes natural products from the cannabis plant as well as synthetic analogues. It is a selective agonist for the CB1 receptor, meaning it binds to this receptor and activates it.

Pharmacology[edit | edit source]

The CB1 receptor is one of two main cannabinoid receptors in the body, the other being the CB2 receptor. These receptors are part of the endocannabinoid system, which plays a role in a variety of physiological processes including pain sensation, mood, and memory. As a selective CB1 agonist, O-1269 has the potential to influence these processes.

Medical Use[edit | edit source]

O-1269 was developed for medical use by Organix Inc., a pharmaceutical company specializing in the development of cannabinoid-based therapies. However, as of now, it is not approved for use in any country.

See Also[edit | edit source]

O-1269 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.